NEMA Research
NEMA Research Inc. is a physician-led, U.S.-based Contract Research Organization founded in 1996 that provides integrated Phase I-IV clinical trial services to pharmaceutical, medical device, and hospital clients, supported by a proprietary KOL Registry and decentralized trial technology.
- Company typePrivate
- Founded1996
- HeadquartersNaples, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What NEMA Research does
NEMA Research Inc. is a privately held, physician-led Contract Research Organization (CRO) founded in 1996 and headquartered in Naples, Florida. The company provides full-service Phase I through Phase IV clinical trial services to pharmaceutical companies, medical device companies, research-oriented hospitals, and individual physicians, with therapeutic experience spanning HIT, DIC, oncology, acute and critical care, pain management, and pharmacoeconomic and health outcomes. Its integrated service portfolio covers feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, medical monitoring, decentralized clinical trial enablement, DSMB services, clinical trial rescue, IRB services (including the first IRB dedicated to nutraceuticals, cosmeceuticals, and dietary supplements), and pharmacoeconomic analysis.
NEMA's technology stack centers on a proprietary pre-feasibility site testing process — combining an online site questionnaire with an on-site meeting and mock protocol run-through — and a tech-enabled Decentralized Clinical Trials platform that supports electronic consent, electronic diaries and assessments, and remote site data monitoring. The firm also maintains a proprietary Key Opinion Leader (KOL) Registry of global thought leaders spanning regulatory, clinical, and research domains, which it draws on across the product lifecycle. The company's medical writing team has produced more than 300 peer-reviewed publications, including in JAMA, and the team has collectively participated in over 400 clinical studies.
NEMA generates revenue through project-based professional services contracts with sponsors; pricing is quote-based and not publicly disclosed. The company employs between 11 and 50 people, operates exclusively in the United States, and has remained privately held since founding with no disclosed outside funding. Its go-to-market is enterprise-focused direct sales, with brand visibility supported by an active publications program and recurring recognition at the Citeline Awards (finalist in 2020, 2021, and 2023).
NEMA Research firmographics
Firmographics- Name
- NEMA Research
- Legal name
- NEMA Research, Inc.
- Website
- https://nemaresearch.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NEMA Research Inc. is a physician-led, U.S.-based Contract Research Organization founded in 1996 that provides integrated Phase I-IV clinical trial services to pharmaceutical, medical device, and hospital clients, supported by a proprietary KOL Registry and decentralized trial technology.
- Ownership category
- akta.pro rank
NEMA Research industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)
Keywords
Where NEMA Research is headquartered
LocationHeadquarters
- HQ city
- Naples
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NEMA Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Clinical Research Services: Full-service CRO providing Phase I-IV clinical trial services including feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, consulting, and clinical trial rescue services. Revenue is generated through project-based professional services contracts with pharmaceutical and medical device companies.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
NEMA Research product offering
Product offeringCore offering
NEMA Research is a fully integrated Contract Research Organization (CRO) providing Phase I-IV clinical trial services for pharmaceutical and medical device companies. Services span feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, and medical monitoring, delivered through a network of physicians, hospitals, and key opinion leaders.
Product overview
NEMA Research is a fully integrated Contract Research Organization (CRO) offering a unified portfolio of Phase I-IV clinical trial services. The core offering consists of Clinical Trial Services Phase I-IV, complemented by specialized sub-products including the KOL Registry (global thought leader network), Decentralized Clinical Trials (tech-enabled remote capabilities), Data Safety Monitoring Services, Clinical Trial Rescue Services, IRB Services, and Health Outcome Pharmacoeconomic Analysis. NEMA Scholars is a separate program supporting young researchers in publishing. The company also employs proprietary research techniques, methodologies, and software as a competitive differentiator. Founded in 1996 and based in Naples, Florida, NEMA differentiates itself through its integrated model and focus on cost-effective, high-quality clinical research solutions.
Differentiator
Problem solved
Functional benefit
Brands
- NEMA Scholars: A unique program designed to encourage young physicians, young scientists, and medical and research scientists to publish their first paper(s) in peer-reviewed journals.
Products and services
- Clinical Trial Services Phase I-IV Comprehensive Phase I through Phase IV clinical trial services covering feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, and medical monitoring for pharmaceutical and medical device sponsors.
- KOL Registry
Quantifiable outcome
- 300+ peer-reviewed publications in journals including JAMA
- +2 more outcomes
Companies that use NEMA Research
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
NEMA Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
NEMA Research partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Pharmaceutical CompaniescoreOngoing partnerships and collaborations providing unique clinical research opportunities for pharmaceutical companies seeking clinical trial services from Phase I to Phase IV. NEMA creates and designs clinical trials as well as places and manages them for pharmaceutical sponsors.
- Medical Device CompaniescorePartnerships with medical device companies providing clinical research services and access to NEMA's network of hospitals and physicians for product development clinical trials.
- Research-Oriented HospitalscoreNEMA Research has developed an extensive network of hospitals for conducting clinical trials, providing unique clinical research opportunities and readily available eligible patient databases.
- Individual Physicians/Key Opinion LeaderscoreNEMA's network includes research-experienced physicians and Key Opinion Leaders (KOLs) specialized for each study. The KOL Registry includes global thought leaders in regulatory, clinical, and research fields ready to provide insight at any stage of product lifecycle.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
NEMA Research competitors and assessment
Company assessmentDirect peers
- Celerion: Specialty early-phase (Phase I/IIa) clinical pharmacology CRO with deep expertise in PK/PD and bioequivalence studies; comparable as a science-focused, mid-sized clinical research services provider.
- Medpace: Mid-size, US-headquartered full-service CRO operating across Phases I-IV with a physician-led model, similar in positioning to NEMA Research as a focused, science-driven alternative to global mega-CROs.
- Worldwide Clinical Trials: Mid-tier CRO offering full-service Phase I-IV clinical development, particularly strong in CNS, cardiometabolic, and rare disease — comparable therapeutic breadth and project-based delivery model to NEMA.
Broad incumbents
- ICON plc: Global full-service CRO formed via the PRA Health Sciences merger, offering end-to-end clinical development and laboratory services across all major therapeutic areas and geographies.
- Syneos Health: Large CRO combining clinical research with commercial launch services; competes for full-service Phase I-IV work and increasingly for decentralized and real-world evidence capabilities.
- Charles River Laboratories: Major CRO/preclinical services provider with broad Phase I-IV, central lab, and discovery capabilities, often competing for sponsor development programs across multiple service lines.
- Labcorp Drug Development: Full-service CRO with integrated central laboratory, bioanalytical, and early development services acquired from Covance — a direct competitor for end-to-end clinical development mandates.
- IQVIA: The largest global CRO with full Phase I-IV capabilities plus technology platforms (eClinical, decentralized trials, real-world evidence) — a key competitor when NEMA pitches against scaled, technology-enabled incumbents.
Emerging players
- Ergomed plc: Specialty CRO with strong oncology and rare disease focus plus pharmacovigilance; comparable as a focused, science-led mid-market CRO building a differentiated therapeutic footprint.
Regional players
- Tigermed: China's largest clinical CRO, offering Phase I-IV services primarily across Asia-Pacific; comparable service model but operating in a different geographic market from US-only NEMA.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
NEMA Research social profiles
Digital presenceNEMA Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
NEMA Research leadership team
Management profileNumber of profiles
Profiles3 records
NEMA Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NEMA Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NEMA Research
What does NEMA Research do?
NEMA Research is a fully integrated Contract Research Organization (CRO) providing Phase I-IV clinical trial services for pharmaceutical and medical device companies. Services span feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, and medical monitoring, delivered through a network of physicians, hospitals, and key opinion leaders.
Is NEMA Research a public or private company?
NEMA Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NEMA Research founded?
NEMA Research was founded in 1996. It employs 11 to 50 people.
Where is NEMA Research based?
NEMA Research is headquartered in Naples, United States, in the North America region.
How does NEMA Research make money?
One revenue line is on record: clinical Research Services.
Who are NEMA Research's main competitors?
Direct peers on record are Celerion, Medpace and Worldwide Clinical Trials. Broad incumbents are ICON plc, Syneos Health, Charles River Laboratories, Labcorp Drug Development and IQVIA. Ergomed plc is listed as an emerging player. Tigermed is listed as a regional player.
Does NEMA Research have an API?
No public API is recorded for NEMA Research.
What industry is NEMA Research in?
NEMA Research's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 5417 and its SIC code is 8731.